Cogent Biosciences
COGT
#2639
Rank
NZ$11.14 B
Marketcap
NZ$72.59
Share price
5.17%
Change (1 day)
407.16%
Change (1 year)

Market capitalization of Cogent Biosciences (COGT)

Market cap: NZ$11.14 Billion

As of December 2025 Cogent Biosciences has a market cap of NZ$11.14 Billion. This makes Cogent Biosciences the world's 2639th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Cogent Biosciences from 2018 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$11.14 B635.06%
2024NZ$1.51 B89.32%
2023NZ$0.80 B-37.08%
2022NZ$1.27 B154.22%
2021NZ$0.50 B3.08%
2020NZ$0.48 B1381.02%
2019NZ$32.79 M-83.33%
2018NZ$0.19 B

End of Day market cap according to different sources

On Dec 13th, 2025 the market cap of Cogent Biosciences was reported to be:

NZ$10.33 Billion
by Nasdaq info icon info icon
NZ$11.14 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Onconova Therapeutics
ONTX
NZ$36.03 M-99.68%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
NZ$1.88 B-83.05%๐Ÿ‡บ๐Ÿ‡ธ USA